BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19585576)

  • 21. Risk of Recurrence After Treatment for Cervical Intraepithelial Neoplasia 3 and Adenocarcinoma In Situ of the Cervix: Recurrence of CIN 3 and AIS of Cervix.
    Swift BE; Wang L; Jembere N; Kupets R
    J Low Genit Tract Dis; 2020 Jul; 24(3):252-258. PubMed ID: 32384365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV.
    Massad LS; Fazzari MJ; Anastos K; Klein RS; Minkoff H; Jamieson DJ; Duerr A; Celentano D; Gange S; Cu-Uvin S; Young M; Watts DH; Levine AM; Schuman P; Harris TG; Strickler HD
    J Low Genit Tract Dis; 2007 Apr; 11(2):90-7. PubMed ID: 17415113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women.
    Trottier H; Mahmud SM; Lindsay L; Jenkins D; Quint W; Wieting SL; Schuind A; Franco EL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):854-62. PubMed ID: 19223559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of vaginal cancer among hysterectomised women with cervical intraepithelial neoplasia: a population-based national cohort study.
    Alfonzo E; Holmberg E; Sparén P; Milsom I; Strander B
    BJOG; 2020 Mar; 127(4):448-454. PubMed ID: 31769577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    Ebisch RMF; Rutten DWE; IntHout J; Melchers WJG; Massuger LFAG; Bulten J; Bekkers RLM; Siebers AG
    J Clin Oncol; 2017 Aug; 35(22):2542-2550. PubMed ID: 28541790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
    Li X; Ding L; Song L; Gao W; Wang L; Wang J
    Int J Cancer; 2020 May; 146(9):2406-2412. PubMed ID: 31290154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
    Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
    Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of a loop electrosurgical excision procedure for cervical intraepithelial neoplasia in a high incidence country.
    Sangkarat S; Ruengkhachorn I; Benjapibal M; Laiwejpithaya S; Wongthiraporn W; Rattanachaiyanont M
    Asian Pac J Cancer Prev; 2014; 15(2):1035-9. PubMed ID: 24568447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2-3 after treatment with a large loop excision of the transformation zone: a retrospective study.
    Fernández-Montolí ME; Tous S; Medina G; Castellarnau M; García-Tejedor A; de Sanjosé S
    BJOG; 2020 Feb; 127(3):377-387. PubMed ID: 31631477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
    Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
    Kocken M; Helmerhorst TJ; Berkhof J; Louwers JA; Nobbenhuis MA; Bais AG; Hogewoning CJ; Zaal A; Verheijen RH; Snijders PJ; Meijer CJ
    Lancet Oncol; 2011 May; 12(5):441-50. PubMed ID: 21530398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic outcomes and risk factors for recurrence after laser vaporization for cervical intraepithelial neoplasia: a single-center retrospective study.
    Kodama K; Yahata H; Okugawa K; Tomonobe H; Yasutake N; Yoshida S; Yagi H; Yasunaga M; Ohgami T; Onoyama I; Asanoma K; Hori E; Shimokawa M; Kato K
    Int J Clin Oncol; 2021 Apr; 26(4):770-776. PubMed ID: 33394202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
    Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
    Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
    Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
    J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.
    Codde E; Munro A; Stewart C; Spilsbury K; Bowen S; Codde J; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Cohen PA
    BJOG; 2018 Jan; 125(1):74-79. PubMed ID: 28678394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
    Acta Cytol; 2006; 50(1):6-15. PubMed ID: 16514834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of High-Risk Human Papillomavirus but Normal Cytology at Test of Cure on Achieving Colposcopy Standards.
    Kalampokas E; Wilson J; Gurumurthy M; Cruickshank ME
    J Low Genit Tract Dis; 2018 Apr; 22(2):110-114. PubMed ID: 29474235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of cervical intraepithelial neoplasia 2 diagnosed by punch biopsy in 131 women.
    Ding Z; Jiang C; Shore T; Pather S; Dalrymple C; Atkinson K; Murali R; Al-Rayyan ES; Luo K; Carter J
    J Obstet Gynaecol Res; 2011 Jul; 37(7):754-61. PubMed ID: 21395898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2.
    Wilkinson TM; Sykes PH; Simcock B; Petrich S
    Am J Obstet Gynecol; 2015 Jun; 212(6):769.e1-7. PubMed ID: 25582099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.